Algernon Pharmaceuticals's total assets for Q1 2025 were C$3.65M, a decrease of -7.34% from the previous quarter. DE:AGW0 total liabilities were C$1.87M for the fiscal quarter, a 5.14% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.